日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

3D Embedded Printing of Complex Biological Structures with Supporting Bath of Pluronic F-127

以 Pluronic F-127 为载体的复杂生物结构的 3D 嵌入式打印

期刊:Polymers
影响因子:
doi:10.3390/polym15173493
Tianzhou Hu, Zhengwei Cai, Ruixue Yin, Wenjun Zhang, Chunyan Bao, Linyong Zhu, Honbo Zhang
3D/类器官
发表日期：2023
文献求助 收藏

Novel case of laparoscopically resected gastric adenocarcinoma concurrent with lanthanum deposition

一例腹腔镜下切除胃腺癌并伴有镧沉积的新型病例报告。

期刊:Clinical Case Reports
影响因子:0.6
doi:10.1002/ccr3.6497
Hirose, Kosuke; Saito, Shunichi; Oshiro, Yumi; Minami, Kazuhito; Ikegami, Koji; Kurahara, Koichi; Honbo, Takuya; Sadanaga, Noriaki; Matsuura, Hiroshi
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Immunosuppression With FTY720 Reverses Cardiac Dysfunction in Hypomorphic ApoE Mice Deficient in SR-BI Expression That Survive Myocardial Infarction Caused by Coronary Atherosclerosis

使用 FTY720 进行免疫抑制可逆转 SR-BI 表达缺陷的低表达 ApoE 小鼠在冠状动脉粥样硬化引起的心肌梗死后存活的心脏功能障碍

期刊:Journal of Cardiovascular Pharmacology
影响因子:2.2
doi:10.1097/FJC.0000000000000312
Luk, Fu Sang; Kim, Roy Y; Li, Kang; Ching, Daniel; Wong, David K; Joshi, Sunil K; Imhof, Isabella; Honbo, Norman; Hoover, Holly; Zhu, Bo-Qing; Lovett, David H; Karliner, Joel S; Raffai, Robert L
心肌梗塞
心血管
动脉粥样硬化
免疫/内分泌
发表日期：2016
文献求助 收藏

The immunosuppressant FTY720 prolongs survival in a mouse model of diet-induced coronary atherosclerosis and myocardial infarction

免疫抑制剂FTY720可延长饮食诱导的冠状动脉粥样硬化和心肌梗死小鼠模型的生存期。

期刊:Journal of Cardiovascular Pharmacology
影响因子:2.2
doi:10.1097/FJC.0000000000000031
Wang, Guanying; Kim, Roy Y; Imhof, Isabella; Honbo, Norman; Luk, Fu Sang; Li, Kang; Kumar, Nikit; Zhu, Bo-Qing; Eberlé, Delphine; Ching, Daniel; Karliner, Joel S; Raffai, Robert L
心肌梗塞
心血管
动脉粥样硬化
免疫/内分泌
发表日期：2014
文献求助 收藏

FTY720 postconditions isolated perfused heart by a mechanism independent of sphingosine kinase 2 and different from S1P or ischemic postconditioning

FTY720 通过一种不依赖于鞘氨醇激酶 2 且不同于 S1P 或缺血后处理的机制，对离体灌注心脏进行后处理。

期刊:Medical Science Monitor Basic Research
影响因子:2
doi:10.12659/MSMBR.883877
Vessey, Donald A; Li, Luyi; Imhof, Isabella; Honbo, Norman; Karliner, Joel S
信号转导
发表日期：2013
文献求助 收藏

S1P lyase: a novel therapeutic target for ischemia-reperfusion injury of the heart.

S1P裂解酶：心脏缺血再灌注损伤的新型治疗靶点

期刊:American Journal of Physiology-Heart and Circulatory Physiology
影响因子:4.1
doi:10.1152/ajpheart.00946.2010
Bandhuvula Padmavathi, Honbo Norman, Wang Guan-Ying, Jin Zhu-Qiu, Fyrst Henrik, Zhang Meng, Borowsky Alexander D, Dillard Lisa, Karliner Joel S, Saba Julie D
心血管
发表日期：2011
文献求助 收藏

A sphingosine kinase form 2 knockout sensitizes mouse myocardium to ischemia/reoxygenation injury and diminishes responsiveness to ischemic preconditioning

鞘氨醇激酶 2 型敲除使小鼠心肌对缺血/复氧损伤敏感，并降低对缺血预处理的反应性

期刊:Oxidative Medicine and Cellular Longevity
影响因子:
doi:10.1155/2011/961059
Donald A Vessey, Luyi Li, Zhu-Qiu Jin, Michael Kelley, Norman Honbo, Jianqing Zhang, Joel S Karliner
信号转导
WB
Mouse
发表日期：2011
文献求助 收藏

Cardioprotective activity of a novel and potent competitive inhibitor of lactate dehydrogenase

一种新型强效乳酸脱氢酶竞争性抑制剂的心脏保护活性

期刊:FEBS Letters
影响因子:3
doi:10.1016/j.febslet.2009.11.022
Kotlyar, Alexander B; Randazzo, Antonio; Honbo, Norman; Jin, Zhu-Qui; Karliner, Joel S; Cecchini, Gary
发表日期：2010
文献求助 收藏

Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemic pre- and postconditioning

鞘氨醇-1-磷酸是一种重要的内源性心脏保护剂，可通过缺血预处理和后处理释放。

期刊:American Journal of Physiology-Heart and Circulatory Physiology
影响因子:4.1
doi:10.1152/ajpheart.00358.2009
Vessey, Donald A; Li, Luyi; Honbo, Norman; Karliner, Joel S
发表日期：2009
文献求助 收藏

Vincristine attenuates doxorubicin cardiotoxicity

长春新碱减轻阿霉素的心脏毒性

期刊:Biochemical and Biophysical Research Communications
影响因子:2.5
doi:10.1016/j.bbrc.2008.06.067
Kanu Chatterjee, Jianqing Zhang, Rong Tao, Norman Honbo, Joel S Karliner
心血管
发表日期：2008
文献求助 收藏